BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12904334)

  • 1. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
    Lo AC; Saab CY; Black JA; Waxman SG
    J Neurophysiol; 2003 Nov; 90(5):3566-71. PubMed ID: 12904334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
    Black JA; Liu S; Hains BC; Saab CY; Waxman SG
    Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI.
    Hains BC; Saab CY; Lo AC; Waxman SG
    Exp Neurol; 2004 Aug; 188(2):365-77. PubMed ID: 15246836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin protects central axons in experimental autoimmune encephalomyelitis.
    Black JA; Waxman SG
    J Neurol Sci; 2008 Nov; 274(1-2):57-63. PubMed ID: 18485368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis.
    Brand-Schieber E; Werner P
    Exp Neurol; 2004 Sep; 189(1):5-9. PubMed ID: 15296830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
    Black JA; Liu S; Carrithers M; Carrithers LM; Waxman SG
    Ann Neurol; 2007 Jul; 62(1):21-33. PubMed ID: 17654737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of conduction in the spinal roots correlates with clinical recovery from experimental autoimmune encephalomyelitis.
    Chalk JB; McCombe PA; Pender MP
    Muscle Nerve; 1995 Oct; 18(10):1093-100. PubMed ID: 7659103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D; Pham-Dinh D; Reynolds R
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE.
    Craner MJ; Hains BC; Lo AC; Black JA; Waxman SG
    Brain; 2004 Feb; 127(Pt 2):294-303. PubMed ID: 14662515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG; Hahn A
    J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis.
    Li FQ; Sempowski GD; McKenna SE; Laskowitz DT; Colton CA; Vitek MP
    J Pharmacol Exp Ther; 2006 Sep; 318(3):956-65. PubMed ID: 16740622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis.
    Kim JH; Budde MD; Liang HF; Klein RS; Russell JH; Cross AH; Song SK
    Neurobiol Dis; 2006 Mar; 21(3):626-32. PubMed ID: 16298135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
    Lo AC; Black JA; Waxman SG
    Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.
    Wang P; Wang ZW; Lin FH; Han Z; Hou ST; Zheng RY
    Biochem Biophys Res Commun; 2011 Mar; 406(1):152-7. PubMed ID: 21303658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
    Liu S; Zwinger P; Black JA; Waxman SG
    J Neurol Sci; 2014 Jun; 341(1-2):8-12. PubMed ID: 24690348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury.
    Kaptanoglu E; Solaroglu I; Surucu HS; Akbiyik F; Beskonakli E
    Acta Neurochir (Wien); 2005 Apr; 147(4):405-12; discussion 412. PubMed ID: 15696267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damage to bulbospinal serotonin-, tyrosine hydroxylase-, and TRH-containing axons occurs early in the development of experimental allergic encephalomyelitis in rats.
    White SR; Samathanam GK; Bowker RM; Wessendorf MW
    J Neurosci Res; 1990 Sep; 27(1):89-98. PubMed ID: 1701489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.